Cargando…

Tumor Suppressor microRNA-138 Suppresses Low-Grade Glioma Development and Metastasis via Regulating IGF2BP2

BACKGROUND: Low-grade gliomas (LGG), approximately constitute one-third of all types of gliomas, are prone to relapse and metastasis. MicroRNA-138 (miR-138) is reported to be dysregulated in diverse human tumors and mainly function as a tumor suppressor. In this study, we analyzed the expression pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yang, Liu, Xinyu, Cheng, Lulu, Li, Li, Wei, Zhenyu, Wang, Zong, Han, Gang, Wan, Xuefeng, Wang, Zaizhong, Zhang, Jianhua, Chen, Chuanliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082711/ https://www.ncbi.nlm.nih.gov/pubmed/32214825 http://dx.doi.org/10.2147/OTT.S232795

Ejemplares similares

microRNA-188 acts as a tumour suppressor in glioma by directly targeting the IGF2BP2 gene
por: Ding, Li, et al.
Publicado: (2022)

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
por: Sun, Chao, et al.
Publicado: (2021)

Network Pharmacology for Analyzing the Key Targets and Potential Mechanism of Wogonin in Gliomas
por: Wang, Zaizhong, et al.
Publicado: (2021)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

Role of IGF2BP3 in trophoblast cell invasion and migration
por: Li, W, et al.
Publicado: (2014)

N(6)-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
por: Zheng, Xin, et al.
Publicado: (2023)

SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis
por: Li, Hao, et al.
Publicado: (2021)

IGF2BP3 as a potential tissue marker for the diagnosis of esophageal high-grade intraepithelial neoplasia
por: Zhang, Jingjing, et al.
Publicado: (2017)

Inhibition of the m(6)A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia
por: Feng, Panpan, et al.
Publicado: (2022)

MNSFβ regulates placental development by conjugating IGF2BP2 to enhance trophoblast cell invasiveness
por: Yang, Qian, et al.
Publicado: (2021)

EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3
por: Pan, Ziwen, et al.
Publicado: (2022)

m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma
por: Fang, Han, et al.
Publicado: (2023)

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
por: Hu, Xiaoge, et al.
Publicado: (2019)

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
por: Shantha Kumara, HMC, et al.
Publicado: (2015)

SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis
por: Zhu, Yan, et al.
Publicado: (2022)

Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip
por: DEMİREL, Esra, et al.
Publicado: (2023)

IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer
por: Chou, Chia-Hsuan, et al.
Publicado: (2020)

IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism
por: Cui, Jie, et al.
Publicado: (2021)

Enhancement of LIN28B-induced hematopoietic reprogramming by IGF2BP3
por: Wang, Saifeng, et al.
Publicado: (2019)

MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2
por: Jiang, Baoen, et al.
Publicado: (2016)

IGF2BP3-induced activation of EIF5B contributes to progression of hepatocellular carcinoma cells
por: LI, XIAOYIN, et al.
Publicado: (2023)

Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk
por: Tang, Weifeng, et al.
Publicado: (2018)

MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma
por: Du, Mingyu, et al.
Publicado: (2022)

FTO Inhibits Epithelial Ovarian Cancer Progression by Destabilising SNAI1 mRNA through IGF2BP2
por: Sun, Meige, et al.
Publicado: (2022)

IGF2BP2 and obesity interaction analysis for type 2 diabetes mellitus in Chinese Han population
por: Wu, Hui-Hui, et al.
Publicado: (2014)

LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis
por: Yang, Juze, et al.
Publicado: (2022)

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
por: Liu, Huidi, et al.
Publicado: (2020)

IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?
por: Xi, Yufeng, et al.
Publicado: (2022)

IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
por: Pickard, Adam, et al.
Publicado: (2015)

PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer
por: Shi, Yunxing, et al.
Publicado: (2023)

IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism
por: Liu, Tian-yue, et al.
Publicado: (2023)

LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression
por: Zhang, Jian, et al.
Publicado: (2020)

CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA–protein ternary complex
por: Ma, Qiang, et al.
Publicado: (2022)

Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment
por: Liu, Yang, et al.
Publicado: (2022)

Identification of an IGF2BP2-Targeted Peptide for Near-Infrared Imaging of Esophageal Squamous Cell Carcinoma
por: Shu, Wenbin, et al.
Publicado: (2022)

Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer
por: Sun, Xin, et al.
Publicado: (2023)

Recognition of RNA N(6)-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation
por: Huang, Huilin, et al.
Publicado: (2018)

Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma
por: Zhang, Jiangbo, et al.
Publicado: (2015)

IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
por: Huang, Wei, et al.
Publicado: (2023)

Evaluation of the Association of IGF2BP2 Variants With Type 2 Diabetes in French Caucasians
por: Duesing, Konsta, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_jhabq2h2m5n8nij6aiu0f3lgd9